33.20
+0.10
+(0.30%)
At close: 1:30:14 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
306,990.00
-66,274.00
733,779.00
219,179.00
138,235.00
Investing Cash Flow
-129,690.00
-461,324.00
-376,184.00
-802,750.00
865,028.00
Financing Cash Flow
-165,739.00
496,574.00
-253,318.00
630,615.00
-954,846.00
End Cash Position
197,398.00
269,569.00
300,614.00
195,250.00
148,625.00
Capital Expenditure
-127,909.00
-451,551.00
-376,184.00
-405,453.00
-192,983.00
Issuance of Debt
100,051.00
800,000.00
1,600,000.00
1,350,000.00
600,000.00
Repayment of Debt
-200,000.00
-200,000.00
-1,750,000.00
-600,000.00
-1,489,740.00
Free Cash Flow
179,081.00
-517,825.00
357,595.00
-186,274.00
-54,748.00
12/31/2020 - 12/20/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1760.TW Panion & Bf Biotech Inc.
82.70
+1.10%
1734.TW Sinphar Pharmaceutical Co.,Ltd.
30.75
+0.33%
4133.TW Abnova (Taiwan) Corporation
29.80
-1.16%
1733.TW Apex Biotechnology Corp.
29.95
0.00%
3164.TW GenMont Biotech Incorporation
19.45
+1.04%
6838.TW Formosa Pharmaceuticals, Inc.
34.00
-0.73%
3176.TWO Medigen Biotechnology Corp.
32.60
-1.21%
4167.TWO Savior Lifetec Corporation
19.75
-0.25%
6550.TW Polaris Group
43.40
+0.46%
6541.TW Tanvex BioPharma, Inc.
65.30
+3.98%